Abstract library

3 results for "Scotti".
#1451 Pancreatic NENs <2 cm Could Represent a New Entity Worth of Further Investigation
Introduction: Surgical approach to the treatment of well-differentiated pancreatic neuroendocrine neoplasms (pNENs) is based on tumor size and Ki67. Surgical removal is not recommended for tumors <2cm, due to their indolent nature. Ki67≤2% and size <2cm are considered indicative of benign tumors. However, size and Ki67 may not correctly predict the prognosis of patients with pNENs <2cm.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Pathology, grading, staging
Presenting Author: MD, PhD Massimo Milione
Keywords: NEN, <2cm, prognosis
#1753 Ki67 Is Able to Predict Pancreatic NENs Prognosis Irrespective of Their Size
Introduction: In pancreatic neuroendocrine neoplasms (pNENs), size <20mm and Ki67≤2% suggest indolent behavior. None of these factors alone predicts prognosis. No other predictive factors have been suggested.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Surgical treatment
Presenting Author: MD, PhD Massimo Milione
Keywords: Ki67, PFS, pancreatic, NEN
#1927 Conditional Survival (CS) Analysis of Liver Resection (LR) for Gastro-Entero-Pancreatic Neuroendocrine Tumor (GEP-NET).
Introduction: LR with curative intent in metastatic GEP-NET is rarely feasible associated with improved survival and symptoms control. CS is the probability that pts will survive an additional number of yrs given that they have already survived at a certain interval
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Surgical treatment
Presenting Author: Surgeon Jorgelina Coppa
Authors: Coppa J, Bongini M, Scotti M, Flores M, ...